FDA Approves SYMBICORT® for Chronic Obstructive Pulmonary Disease (COPD)

Links shared publicly online about this topic.

  • 2,224
    total visits

FDA Approves SYMBICORT® for Chronic Obstructive Pulmonary Disease (COPD)

astrazeneca-us.com

Learn how SYMBICORT provides a new, fast-acting combination treatment option for millions of Americans with debilitating lung disease.

View full resource at astrazeneca-us.com

Tags: Asthma Medication, Lung, COPD, Disease and Condition, FDA, Symbicort, AstraZeneca, Pulmonology

  • Share

Most Recently Shared on February 28, 2009 at 12:32 pm By:

eyeonfda eyeonfda

FDA approves AZ's SYMBICORT® for Chronic Obstructive Pulmonary Disease (COPD) http://bit.ly/dHzDY

3 years ago...

BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval | BioPortfolio.com

bioportfolio.com — “From BioPortfolio: Allergan, Inc. (NYSE: AGN) announced today that April 15, 2012 will mark the 10-year anniversary of the U.S. Food and Drug Administrationâ??s (FDA) approv...View full resource at bioportfolio.com

  • View Related
  • Share

Most Recently Shared on April 13, 2012 at 1:46 pm By:

Dermatology_bio BioPF Dermatology Dermatology and Health News Feed

BioPortfolio News BOTOXÂ Cosmetic onabotulinumtoxinA Celebrates 10Year Anniversary of U.S. Foo... http://t.co/ogZ38usV BioPortfolio News

7 days ago...

Americans stuck on Botox for 10 years now – USATODAY.com

usatoday.com — “The toxin's popularity has skyrocketed, along with its medical uses, since FDA approval a decade ago this week.View full resource at usatoday.com

  • View Related
  • Share

Most Recently Shared on April 12, 2012 at 11:56 am By:

FDA Approves Alzheimer's Test Developed by Eli Lilly - WSJ.com

online.wsj.com — “The FDA approved an Eli Lilly test that can help detect Alzheimer's—a potential boon to treatment and developing drugs against the disease.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on April 8, 2012 at 11:34 pm By:

Lilly says FDA approves brain imaging agent - Yahoo! News

news.yahoo.com — “From Yahoo! News: Eli Lilly and Co. said late Friday that the Food and Drug Administration approved Amyvid, a diagnostic imaging agent that is intended to help diagnose Alzheimer's disease.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on April 7, 2012 at 11:39 pm By:

Diagnostic_Test Diagnostic_Test OW Health

Lilly says FDA approves brain imaging agent: Eli Lilly and Co. said late Friday that the Food and Drug Administr... http://t.co/KiJpJNHt

2 weeks ago...

Weight loss pill Qnexa wins panel vote and awaits approval

news-medical.net — “The drug was rejected in a 10-6 vote the first time it came before a Food and Drug Administration (FDA) advisory panel, in 2010, due to safety concerns. However when the medication returned for another review in February, the advisory committee gave it near-unanimous approval (20-2). Because the FDA often follows the advisory panel's advice, Qnexa is likely to get FDA approval, probably by mid-April.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on April 5, 2012 at 11:08 pm By:

Diet_News News-Medical.Net Health News

Diet News: Weight loss pill Qnexa wins panel vote and awaits approval: The drug was rejected in a 10-6 vote the ... http://t.co/rGbONdEq

2 weeks ago...

Pharmacy OneSource

rph.com — “The combined company of Pharmacy OneSource and Healthprolink enables swift and safe healthcare through innovative, web-based software solutions.View full resource at rph.com

  • View Related
  • Share

Most Recently Shared on April 5, 2012 at 5:14 pm By:

PharmOneSource Pharmacy OneSource

What did the FDA approve this week? Read to find out: http://t.co/FlA0waFm

2 weeks ago...

preview

emailactivity.ecn5.com — “previewView full resource at emailactivity.ecn5.com

  • View Related
  • Share

Most Recently Shared on April 5, 2012 at 12:30 pm By:

New diet drug Qnexa awaits FDA approval amid safety questions – USATODAY.com

usatoday.com — “Some experts say it could potentially help dieters lose about 10% of their weight, but with its former FDA rejection, how safe is it?View full resource at usatoday.com

  • View Related
  • Share

Most Recently Shared on April 4, 2012 at 10:45 pm By:

USATODAYhealth Maureen Linke Health News

Diet drug Qnexa awaits FDA approval amid safety questions http://t.co/YjlUT7Bn

2 weeks ago...

preview

emailactivity.ecn5.com — “previewView full resource at emailactivity.ecn5.com

  • View Related
  • Share

Most Recently Shared on April 3, 2012 at 6:14 pm By:

Is FDA's approval process good enough? - CBS News Video

cbsnews.com — “CBS News video: Is FDA's approval process good enough? - Dr. Robert Hauser had confidence in the cardiac defibrillator he implanted in teenager Joshua Oukrop. But when the device failed and Josh died, Dr. Hauser began a quest to discover why. Jim Axelrod reports on what he found.View full resource at cbsnews.com

  • View Related
  • Share

Most Recently Shared on April 1, 2012 at 8:34 pm By:

AbbieCitron Abbie Citron, RN Nurse

Is FDA's approval process good enough? - CBS News Video http://t.co/UiHOMdxq

3 weeks ago...

Text of H.R.3847 as Introduced in House: SOUND Devices Act of 2012 - U.S. Congress - OpenCongress

opencongress.org — “Full bill text of H.R.3847 SOUND Devices Act of 2012 on OpenCongress.orgView full resource at opencongress.org

  • View Related
  • Share

Most Recently Shared on March 30, 2012 at 5:28 pm By:

CUsafepatient Safe Patient Project

Sen draft bill won't let FDA remove recalled devices 4rm predicate list--pred nullification. SOUND Act does http://t.co/ANUW11Fe #sppchat

3 weeks ago...

FDA advisory panel: CV data needed pre-, post-approval of obesity drugs

endocrinetoday.com — “The FDA Endocrinologic and Metabolic Drugs Advisory Committee voted 17-6 that obesity drugs without a theoretic risk or signal for cardiovascular haView full resource at endocrinetoday.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 10:00 pm By:

Consumer Reports Warns of Lax Testing for Medical Devices - ABC News

abcnews.go.com — “Consumer Reports advises patients to do their homework before having medical devices implanted in their bodies.  Companies that sell defibrillators, stents or other such products can get approval from the Food and Drug Administration without their undergoing rigorous testing, Consumer Reports warned in a new report. The FDA collects information on medical device malfunctions that lead to death. Data highlighted by Consumer Reports show 686 deaths from 2009 to last year connected to automateView full resource at abcnews.go.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 7:39 pm By:

HITpol HealthIT Policy Health News and Health IT

Consumer Reports Warns of Lax Testing for Medical Devices: Consumer Reports advises patients to do their homewor... http://t.co/z5sM68RZ

3 weeks ago...

Pharmacy OneSource

rph.com — “The combined company of Pharmacy OneSource and Healthprolink enables swift and safe healthcare through innovative, web-based software solutions.View full resource at rph.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 4:59 pm By:

Avioq Receives FDA Approval for HTLV-I/II Test | IVD Technology

ivdtechnology.com — “Avioq Inc. has received approval from FDA for the Avioq HTLV-I/II Microelisa System. The test is used for the qualitative detection of antibodies to Human T-Lymphotropic Virus Type I (HTLV-I) and Human T-Lymphotropic Virus Type II (HTLV-II) in human serum or plasma.View full resource at ivdtechnology.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 4:42 pm By:

Advertisement